{
    "paper_id": "dfbdd7c6ac2c52d661182f4240a5c0969d22205d",
    "metadata": {
        "title": "Smallpox Vaccines for Biodefense",
        "authors": [
            {
                "first": "Richard",
                "middle": [
                    "B"
                ],
                "last": "Kennedy",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Mayo Vaccine Research Group",
                    "institution": "",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Inna",
                "middle": [],
                "last": "Ovsyannikova",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Mayo Vaccine Research Group",
                    "institution": "",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Gregory",
                "middle": [
                    "A"
                ],
                "last": "Poland",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Mayo Vaccine Research Group",
                    "institution": "",
                    "location": {}
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Few diseases can match the enormous impact that smallpox has had on mankind. Its influence can be seen in the earliest recorded histories of ancient civilizations in Egypt and Mesopotamia. With fatality rates up to 30%, smallpox left its survivors with extensive scarring and other serious sequelae. It is estimated that smallpox killed 500 million people in the 19 th and 20 th centuries. Given the ongoing concerns regarding the use of variola as a biological weapon, this review will focus on the licensed vaccines as well as current research into next-generation vaccines to protect against smallpox and other poxviruses.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "human life after a laboratory exposure in England. In May of 1980 the World Health Organization declared that smallpox had been eradicated. [6] Pathology Infection typically occurred primarily through the respiratory route or contact with contaminated clothing and bedding, although airborne exposure cannot be ruled out. [2, 7] This was followed by a prolonged, asymptomatic incubation period of 12-14 days which culminated in a 2-4 day prodromal phase marked by high fever, headache, backache, nausea and prostration. [8, 9] The characteristic rash began on the face and extremities and eventually covered the entire body. The lesions begin as small reddish macules which, over the next several weeks, enlarge and become pustules several millimeters in size. The lesions eventually scab over leaving behind extensive scarring. Other long-term sequelae can include blindness, encephalitis, secondary infections and arthritis. Clinical symptoms varied widely and are likely attributable to infectious dose, host health, pre-existing immunity and genetic factors of both host and virus. Fatality rates can be as high as 30%, with death usually attributed to toxemia, hypotension and multi-organ failure; however the exact causes of death are not fully understood and it is likely that both viral cytopathic effects and inflammatory immune mediators contribute to mortality. [9] Prevention and Treatment",
            "cite_spans": [
                {
                    "start": 140,
                    "end": 143,
                    "text": "[6]",
                    "ref_id": null
                },
                {
                    "start": 322,
                    "end": 325,
                    "text": "[2,",
                    "ref_id": null
                },
                {
                    "start": 326,
                    "end": 328,
                    "text": "7]",
                    "ref_id": null
                },
                {
                    "start": 520,
                    "end": 523,
                    "text": "[8,",
                    "ref_id": null
                },
                {
                    "start": 524,
                    "end": 526,
                    "text": "9]",
                    "ref_id": null
                },
                {
                    "start": 1373,
                    "end": 1376,
                    "text": "[9]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The earliest effective preventive measure for smallpox was variolation, the intentional introduction of smallpox material into a healthy host. [1,2] There were two main techniques: 1) dried scab material inhalation, and 2) pus from active lesions scratched into the skin. Both approaches resulted in full-fledged cases of smallpox, the vast majority of which had far milder symptoms with case fatality rates of 1-2%. One of the first large-scale uses of this treatment in North America was when General Washington ordered the variolation of US troops during the Revolutionary War.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "[10] The eradication efforts were made possible, in part, by the availability of an effective vaccine. Although Jenner's initial work focused on cowpox, by the mid twentieth century most vaccines were based on vaccinia, an immunologically cross-protective poxvirus. Although the origins of vaccinia virus are unknown, the vaccine was remarkably effective, with take rates over 97%. Protection was believed to last for 3-10 years and revaccination was required every 10 years.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "[2] Recent research has shown that immune responses to vaccinia can be detected over 70 years after vaccination, however, the level of protection afforded by these immune markers is not known. [11] [12] [13] [14] [15] [16] [17] [18] There are few treatments for smallpox, underscoring the need for safe and effective vaccines. Hyperimmune serum obtained from recent vaccine recipients has been used to produce vaccinia immune globulin (VIG) which is used to treat both smallpox outbreaks and vaccine complications. [19] Similarly, cidofovir and related anti-viral agents have shown inhibitory activity against poxviruses in vitro and in animal challenge models. [20] [21] [22] Poxvirus antivirals are an area of active research and are likely to play key roles supplementing vaccines in biodefense preparations against smallpox.",
            "cite_spans": [
                {
                    "start": 193,
                    "end": 197,
                    "text": "[11]",
                    "ref_id": null
                },
                {
                    "start": 198,
                    "end": 202,
                    "text": "[12]",
                    "ref_id": null
                },
                {
                    "start": 203,
                    "end": 207,
                    "text": "[13]",
                    "ref_id": null
                },
                {
                    "start": 208,
                    "end": 212,
                    "text": "[14]",
                    "ref_id": null
                },
                {
                    "start": 213,
                    "end": 217,
                    "text": "[15]",
                    "ref_id": null
                },
                {
                    "start": 218,
                    "end": 222,
                    "text": "[16]",
                    "ref_id": null
                },
                {
                    "start": 223,
                    "end": 227,
                    "text": "[17]",
                    "ref_id": null
                },
                {
                    "start": 228,
                    "end": 232,
                    "text": "[18]",
                    "ref_id": null
                },
                {
                    "start": 515,
                    "end": 519,
                    "text": "[19]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 662,
                    "end": 666,
                    "text": "[20]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 667,
                    "end": 671,
                    "text": "[21]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 672,
                    "end": 676,
                    "text": "[22]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "With the recent rise in terrorism activity (including bioterrorism), and concerns regarding statesponsored biological weapons programs have led to significant efforts in the areas of biodefense and biopreparedness. [23] Both the Soviet Union and Iraq are known to have had large biological weapons programs which included smallpox. [24, 25] Variola major, the causative agent of smallpox is considered a top bioterrorism agent. [26] 1) It is a disfiguring illness with a high mortality rate, 2) it is a highly contagious pathogen with an extremely low infectious dose, 3) the disease has a long, asymptomatic incubation period, 4) there are no effective treatments and limited vaccine stocks, 5) an outbreak would cause widespread panic and societal disruption and, 6) since vaccination ceased over 30 years ago, and the present population is largely susceptible and vaccine recipients are likely to have waning immunity. Notably a contemporary release of smallpox would not be its first use as a weapon (Table 1) .",
            "cite_spans": [
                {
                    "start": 215,
                    "end": 219,
                    "text": "[23]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 332,
                    "end": 336,
                    "text": "[24,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 337,
                    "end": 340,
                    "text": "25]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 428,
                    "end": 432,
                    "text": "[26]",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [
                {
                    "start": 1004,
                    "end": 1013,
                    "text": "(Table 1)",
                    "ref_id": null
                }
            ],
            "section": "Smallpox as a bioweapon"
        },
        {
            "text": "First generation vaccines developed during the eradication effort consist of live vaccinia virus (See Table 2 ). Dryvax\u00ae, the vaccine used in the US is based on the New York City Board of Health (NYCBOH) strain of vaccinia and together with the Lister strain used in Europe, Africa and Asia was deemed safer than other vaccine strains.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 102,
                    "end": 109,
                    "text": "Table 2",
                    "ref_id": null
                }
            ],
            "section": "Current Vaccines"
        },
        {
            "text": "[2] First generation vaccines were produced by infecting the abdomen and flanks of calves or other large animals. The infected areas were then scraped to collect the lymph exudate and virus was purified, stabilized with glycerol and phenol, and in many cases lyophilized. The resulting vaccine was introduced into the epidermal layer of the skin using a bifurcated needle with multiple punctures. Production of these vaccines ceased in the 1970's and 1980's.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Current Vaccines"
        },
        {
            "text": "Three to four days following successful vaccination a pock forms at the vaccine site as a result of local viral replication and inflammatory response. Over the first week, the pock grows to 10-15 mm in size, fills with pus and eventually drains and scabs over. Approximately 3-4 weeks after vaccination the scab will fall off leaving a small scar.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Current Vaccines"
        },
        {
            "text": "Humoral responses begin to develop within 2 weeks of vaccination, with neutralizing antibody titers peaking around day 28. [16, 27] Antibody titers decline in the first several years following vaccination and then stabilize and remain constant for decades.",
            "cite_spans": [
                {
                    "start": 123,
                    "end": 127,
                    "text": "[16,",
                    "ref_id": null
                },
                {
                    "start": 128,
                    "end": 131,
                    "text": "27]",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [],
            "section": "Current Vaccines"
        },
        {
            "text": "[11] Robust CD4 and CD8 T cell responses occur after immunization and reach their peak between 2-5 weeks post vaccination. Similar to humoral immunity, virus-specific T cells can be detected for decades following vaccination, with CD4+ T cells showing greater longevity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Current Vaccines"
        },
        {
            "text": "[11] Unfortunately, the magnitude of the protective immune response has not been clearly defined. One study showed that subjects with neutralizing antibody titers > 1:32 were less susceptible to infection [28] , while a similar study found that titers >1:20 were protective. [29] Unfortunately, no similar data are available for cell-mediated responses.",
            "cite_spans": [
                {
                    "start": 205,
                    "end": 209,
                    "text": "[28]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 275,
                    "end": 279,
                    "text": "[29]",
                    "ref_id": "BIBREF10"
                }
            ],
            "ref_spans": [],
            "section": "Current Vaccines"
        },
        {
            "text": "The live virus vaccines used during the eradication efforts were not without side-effects and complications, in fact they are among the most reactogenic of all FDA-approved vaccines. Common side effects include: fever, headache, pruritis, lymphadenopathy, fatigue, muscle aches and nausea. Although rare, life-threatening conditions such as postvaccinal encephalitis, progressive vaccinia and eczema vaccinatum, myopericarditis or generalized vaccinia can occur. [30] [31] [32] Historically, for every million vaccine recipients there were 1-2 deaths and hundreds of cases with complications severe enough to require hospitalization. [33] If the current population of the United States were vaccinated, it might result in several hundred deaths and tens of thousands of hospitalizations. In the absence of endemic smallpox this risk was not acceptable, and large-scale vaccination halted in 1972 in the United States and by 1980 in most other countries as well. From a biodefense standpoint these vaccine safety concerns would be of secondary importance to the need to quickly and efficiently break the chain of transmission and contain the outbreak.",
            "cite_spans": [
                {
                    "start": 463,
                    "end": 467,
                    "text": "[30]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 468,
                    "end": 472,
                    "text": "[31]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 473,
                    "end": 477,
                    "text": "[32]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 634,
                    "end": 638,
                    "text": "[33]",
                    "ref_id": "BIBREF14"
                }
            ],
            "ref_spans": [],
            "section": "Current Vaccines"
        },
        {
            "text": "As concerns regarding bioterrorism increased in the earliest years of the 21 st century, national stockpiles of smallpox vaccines were found to be extremely limited. In 2005 the stockpile was estimated to have 15 million doses of lyophilized Dryvax vaccine and 85 million doses of frozen Aventis Pasteur Smallpox Vaccine (APSV). [34] Other countries were found to have similarly limited stockpiles of smallpox vaccine, enough for an estimated 10% of the world population. [35] In the early 2000's the US government re-instituted large scale vaccination programs among the military and among civilian healthcare workers. [32, 36, 37] Consequently considerable effort was put into extending the current stocks and development of replacement vaccines. Given the lack of endemic smallpox all new smallpox vaccines are being compared to Dryvax\u00ae in terms of both safety and immunogenicity. [38] Controlled studies indicated that Dryvax and other first-generation vaccines (APSV, Lister) could be diluted at least 5-fold without a significant drop in either take rates or immunogenicity [39] [40] [41] [42] [43] , although other groups have argued that dilution will increase the risk of ineffective inoculations and may hamper ring vaccine strategies. [44] Acambis and Baxter laboratories plaque purified a NYCBOH isolate from Dryvax\u00ae with an improved safety profile in animal models and used this strain to create a cell-culture based vaccine; ACAM2000. [45, 46] This vaccine has been through multiple clinical trials and was found to have the same take rate, lesion size and a similar rate of adverse events as Dryvax. [47] Neutralizing antibody titers induced by ACAM2000 were slightly lower than Dryvax in one study [47] but equivalent in others [45, 48] , while T cell responses showed no significant differences. In a non-human primate study, ACAM2000 was found to be as effective as Dryvax in preventing disease following a lethal monkeypox challenge. [49] Interestingly, ACAM2000 takes rates decreased significantly upon dilution. [48] ACAM2000 received FDA approval in 2007 [50] . By 2004 Acambis had produced 200 million doses of the vaccine for the national stockpile [45] and is contracted to produce more.",
            "cite_spans": [
                {
                    "start": 329,
                    "end": 333,
                    "text": "[34]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 472,
                    "end": 476,
                    "text": "[35]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 620,
                    "end": 624,
                    "text": "[32,",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 625,
                    "end": 628,
                    "text": "36,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 629,
                    "end": 632,
                    "text": "37]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 884,
                    "end": 888,
                    "text": "[38]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1080,
                    "end": 1084,
                    "text": "[39]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1085,
                    "end": 1089,
                    "text": "[40]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1090,
                    "end": 1094,
                    "text": "[41]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1095,
                    "end": 1099,
                    "text": "[42]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 1100,
                    "end": 1104,
                    "text": "[43]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 1246,
                    "end": 1250,
                    "text": "[44]",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 1449,
                    "end": 1453,
                    "text": "[45,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1454,
                    "end": 1457,
                    "text": "46]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 1615,
                    "end": 1619,
                    "text": "[47]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 1714,
                    "end": 1718,
                    "text": "[47]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 1744,
                    "end": 1748,
                    "text": "[45,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1749,
                    "end": 1752,
                    "text": "48]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 1953,
                    "end": 1957,
                    "text": "[49]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 2033,
                    "end": 2037,
                    "text": "[48]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 2077,
                    "end": 2081,
                    "text": "[50]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 2173,
                    "end": 2177,
                    "text": "[45]",
                    "ref_id": "BIBREF26"
                }
            ],
            "ref_spans": [],
            "section": "Current Vaccines"
        },
        {
            "text": "In addition to licensed vaccines, a number of other vaccine candidates are in various stages of development. [51] [52] [53] [54] These include other live vaccinia strains, live attenuated strains deficient in one or more viral genes (believed to be safer alternatives to conventional vaccinia strains), and inactivated or subunit vaccines that potentially offer even greater safety profiles.",
            "cite_spans": [
                {
                    "start": 109,
                    "end": 113,
                    "text": "[51]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 114,
                    "end": 118,
                    "text": "[52]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 119,
                    "end": 123,
                    "text": "[53]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 124,
                    "end": 128,
                    "text": "[54]",
                    "ref_id": "BIBREF35"
                }
            ],
            "ref_spans": [],
            "section": "Development of New Vaccines"
        },
        {
            "text": "Initial work on tissue culture smallpox vaccines was performed in the 1970's, and again emphasized in the early 2000's as replacements for the aging calf-lymph products. These vaccines sought to retain the immunogenicity of the live vaccines while controlling the production conditions in order to curtail non-sterile handling of the vaccine components, and eliminate bacterial, viral, and fungal adventitious agents. [55] These vaccine candidates include: ACAM1000 and ACAM2000 produced by Acambis from plaque purified NYCBOH isolates grown in MRC-5 and Vero cells respectively [45, 56] , Cell-culture smallpox vaccine (CCSV), another NYCBOH-based vaccine grown in MRC-5 cells and developed by DynPort, [57] , and Elstree-BN, a Bavarian-nordic product based on the Lister strain. [51] Most of these strains have undergone extensive side-by-side testing with Dryvax\u00ae or Lister vaccines and have similar safety and immunogenicity profiles. [58] ",
            "cite_spans": [
                {
                    "start": 418,
                    "end": 422,
                    "text": "[55]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 579,
                    "end": 583,
                    "text": "[45,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 584,
                    "end": 587,
                    "text": "56]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 704,
                    "end": 708,
                    "text": "[57]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 781,
                    "end": 785,
                    "text": "[51]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 939,
                    "end": 943,
                    "text": "[58]",
                    "ref_id": "BIBREF39"
                }
            ],
            "ref_spans": [],
            "section": "Live smallpox vaccines produced in tissue culture"
        },
        {
            "text": "During the eradication effort a number of attempts were made to create less pathogenic virus strains with a corresponding increase in vaccine safety. [34] While most of these newer strains were not sufficiently immunogenic for use in vaccines, several promising candidates remain.",
            "cite_spans": [
                {
                    "start": 150,
                    "end": 154,
                    "text": "[34]",
                    "ref_id": "BIBREF15"
                }
            ],
            "ref_spans": [],
            "section": "Replication competent, attenuated smallpox vaccines"
        },
        {
            "text": "LC16m8 was developed through serial passage of VACV Lister through rabbit kidney cells. [59, 60] The resulting strain was less virulent and was used in Japan in the 1970's. [60] LC16m8 was found to have similar take rates and levels of neutralizing antibodies than Lister, with fewer adverse events and febrile reactions. [61] LC16m8 is one of the candidates for the creation of a US stockpile of attenuated smallpox vaccine.",
            "cite_spans": [
                {
                    "start": 88,
                    "end": 92,
                    "text": "[59,",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 93,
                    "end": 96,
                    "text": "60]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 173,
                    "end": 177,
                    "text": "[60]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 322,
                    "end": 326,
                    "text": "[61]",
                    "ref_id": "BIBREF42"
                }
            ],
            "ref_spans": [],
            "section": "Replication competent, attenuated smallpox vaccines"
        },
        {
            "text": "Modified Virus Ankara (MVA) was developed through the serial passage of VACV Ankara through chick embryo fibroblasts. [62] After 572 passages, the virus lost ~15% of its genome and the ability to replicate in most mammalian cells. [63] It was used in Germany in the late 1960's to vaccinate over 100,000 individuals with very few adverse events. As smallpox did not circulate in Germany during or after this time period, there are no efficacy data on MVA. Newer versions of MVA are being produced by a number of manufacturers including: ACAM3000 by Acambis (www.clinicaltrials.gov # NCT00079820 last accessed 7/14/2009), IMVAMUNE by Bavarian Nordic [64, 65] , and TBC-MVA by Therion Biologics Corporation [66] . MVA is also a top candidate for inclusion in the US stockpile as an attenuated vaccine. NYVAC, another highly attenuated vaccine strain was derived from the parental Copenhagen vaccinia strain by deletion of 19 ORFs including the thymidine kinase, ribonucleotide reductase, complement binding, hemagglutinin and other genes. [67] While NYVAC is deemed to be a \"safer\" vaccine candidate, direct comparisons with Dryvax or Lister-based vaccines have shown that NYVAC possesses inferior immunogenicity. [18, 68, 69] From the standpoint of biodefense preparations against poxviruses, NYVAC is not an optimal vaccine candidate. On the other hand, foreign antigens can be readily incorporated in NYVAC based vectors and induce robust immunity. NYVAC is therefore a promising vehicle for the development of vaccines against other diseases. [69] [70] [71] A replication defective vaccine based on the Lister strain (dVV-L) was created through the deletion of the uracil-DNA-glycosylase (UDG) gene. [72] The resulting vaccine, while replication incompetent outside of certain cell lines which provide exogenous UDG is still capable of initial infection and early gene expression. Early work found that this vaccine candidate had an enhanced safety profile compared to wild-type Lister vaccine. [73] Mouse vaccination and lethal challenge studies found that dVV-L induced protective T and B cell responses against cowpox or vaccinia virus but required higher vaccine doses to prevent death in response to more virulent natural mouse pathogen, ectromelia virus. [74] The Dairen strain was used primarily in Japan during the eradication effort and more recently was used to create the attenuated Dairen-I strain. [75, 76] This strain lacks several host range and immunomodulatory genes [77] which restrict its replicative potential and may enhance its safety profile. Similar to NYVAC, Dairen-I has served as a useful vector in the development of vaccines against mycobacterium, HIV, SARS and other pathogens. [78] [79] [80] A variety of other attenuated vaccinia virus strains have been created through the selected deletion or alteration of host range genes, virulence factors and immunomodulatory genes. [81] [82] [83] [84] [85] [86] [87] These recombinant vaccinia strains have been shown to grow to lower titers in various organs, and/or exhibit less toxicity and morbidity in immunocompromised animal models. Other groups have used genetic engineering to incorporate growth factors, cytokines, chemokines and innate immune activators into vaccinia virus in an attempt to boost immune responses after infection. [88] Overall, attenuated vaccinia strains are far safer in animal models, especially those with defective immune responses, and in a number of cases (MVA, LC16m8) induce fewer side effects in human populations. Unfortunately a growing body of literature indicates that they are less immunogenic than their conventional vaccine counterparts, requiring high doses of antigen and/or repeat immunization to induce similar levels of antibody titers or cellular immunity.",
            "cite_spans": [
                {
                    "start": 118,
                    "end": 122,
                    "text": "[62]",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 231,
                    "end": 235,
                    "text": "[63]",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 649,
                    "end": 653,
                    "text": "[64,",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 654,
                    "end": 657,
                    "text": "65]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 705,
                    "end": 709,
                    "text": "[66]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 1037,
                    "end": 1041,
                    "text": "[67]",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 1217,
                    "end": 1220,
                    "text": "68,",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 1221,
                    "end": 1224,
                    "text": "69]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 1545,
                    "end": 1549,
                    "text": "[69]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 1550,
                    "end": 1554,
                    "text": "[70]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 1555,
                    "end": 1559,
                    "text": "[71]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 1702,
                    "end": 1706,
                    "text": "[72]",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 1997,
                    "end": 2001,
                    "text": "[73]",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 2263,
                    "end": 2267,
                    "text": "[74]",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 2413,
                    "end": 2417,
                    "text": "[75,",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 2418,
                    "end": 2421,
                    "text": "76]",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 2486,
                    "end": 2490,
                    "text": "[77]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 2710,
                    "end": 2714,
                    "text": "[78]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 2715,
                    "end": 2719,
                    "text": "[79]",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 2720,
                    "end": 2724,
                    "text": "[80]",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 2907,
                    "end": 2911,
                    "text": "[81]",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 2912,
                    "end": 2916,
                    "text": "[82]",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 2917,
                    "end": 2921,
                    "text": "[83]",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 2922,
                    "end": 2926,
                    "text": "[84]",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 2927,
                    "end": 2931,
                    "text": "[85]",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 2932,
                    "end": 2936,
                    "text": "[86]",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 2937,
                    "end": 2941,
                    "text": "[87]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 3317,
                    "end": 3321,
                    "text": "[88]",
                    "ref_id": "BIBREF69"
                }
            ],
            "ref_spans": [],
            "section": "Replication competent, attenuated smallpox vaccines"
        },
        {
            "text": "[18] Another interesting observation is that subclones with markedly different behavioral characteristics exist within live viral stocks, and outgrowth of these lines may have unforeseen effects on safety, immunogenicity or both. [89] In the absence of endemic smallpox it is not known if these vaccines will provide full protection or merely attenuate disease symptoms. One potential option would be to use these safer vaccines in individuals with compromised immunity, while another approach would be to provide these vaccines to everyone in the population as a priming dose. In this case, a partially protected population may serve as a deterrent to bioterrorism and the conventional vaccine would always be available in the case of an outbreak or biological attack. In any case, these attenuated vaccine formulations are a valuable component of biodefense preparations.",
            "cite_spans": [
                {
                    "start": 230,
                    "end": 234,
                    "text": "[89]",
                    "ref_id": "BIBREF70"
                }
            ],
            "ref_spans": [],
            "section": "Replication competent, attenuated smallpox vaccines"
        },
        {
            "text": "In the mid-20 th century a great deal of effort went into the development of inactivated smallpox vaccines, with limited success. [90, 91] Although these vaccines exhibited far greater safety profiles, and induced strong humoral immunity; the resulting responses were unable to control infection and prevent illness in animal models. [92, 93] This may be attributed to the lack of key immunogenic epitopes within the killed vaccines. These formulations lack the extracellular enveloped virions which contain an extra lipid membrane with several additional viral proteins. [94] [95] [96] These proteins are targets of neutralizing antibody responses and immunity to both the intracellular and extracellular virions is likely needed for complete protection.",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 134,
                    "text": "[90,",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 135,
                    "end": 138,
                    "text": "91]",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 334,
                    "end": 338,
                    "text": "[92,",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 339,
                    "end": 342,
                    "text": "93]",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 572,
                    "end": 576,
                    "text": "[94]",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 577,
                    "end": 581,
                    "text": "[95]",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 582,
                    "end": 586,
                    "text": "[96]",
                    "ref_id": "BIBREF77"
                }
            ],
            "ref_spans": [],
            "section": "Inactivated smallpox vaccines"
        },
        {
            "text": "The development of protein, peptide or nucleic acid based subunit vaccines for preventing smallpox is an active area of investigation. Most groups have focused on the inclusion of viral proteins targeted by humoral immunity, although with the recent identification of CD4 and CD8 T cell epitopes, cellular responses to poxviruses are beginning to be taken into account as well. [97, 98] [99] Several groups have found that combinations of membrane and virion proteins (A27L, A33R, B5R, H3L, L1R) or DNA are far more effective than single protein vaccines and provide excellent protectin in both mice and non-human primate models. [99] [100] [101] [102] [103] [104] [105] [106] One consideration that must be taken into account is the genetic diversity of poxviruses. The vaccines are all based on vaccinia virus whereas the most important pathogenic poxviruses are variola and monkeypox. Cross-protective immunity is a direct result of antigenic similarity between the viruses. Using whole viruses provides a large mixture of vaccinia antigens, many of which are highly conserved between poxvirus strains. With protein or DNA based subunit vaccines the selection of antigens is severely limited. Heterogeneity within individual proteins may have negative consequences on vaccine efficacy. [107, 108] One alternative to this is to base vaccine components on variola homologs rather than the vaccinia proteins. [109] The identification of HLA class I and class II restricted epitopes from poxviruses has opened the door to the development of safe and immunogenic peptide-based vaccines. [110] [111] [112] [113] [114] [115] [116] [117] [118] Another area of investigation is the use of different delivery routes, including mucosal vaccines [119, 120] and plant-based formulations. [121] Conclusions and looking to the future Given the tremendous effect a biological attack with smallpox would cause, it is imperative that we are properly prepared. Vaccines are among the most cost-effective of healthcare measures and play key roles in biodefense preparations both through deterrent action and as preventive measures. Although several elements of our bio-preparedness efforts are now being accomplished (sufficient vaccine doses for the US population, new anti-virals), much work remains as many countries have insufficient doses for their population and live virus vaccines remain problematic in today's environment of extreme sensitivity to adverse vaccine reactions. Numerous potentially safer vaccine products are in various stages of research and development but will require rigorous testing to ensure that they induce immunity equivalent to conventional smallpox vaccines. To this end, further work needs to be done to refine animal models for testing new smallpox vaccines as small animal studies using different poxviruses can produce conflicting results, and non-human primate models do not fully recapitulate human exposure to smallpox. [122] Another avenue of research that should be further developed is that of immunogenetics and understanding why some individuals are predisposed to ineffective vaccine responses or even adverse events. [123] [124] [125] The development of simple screening tests would allow us to steer individual patients toward vaccines best suited to their individual requirements. [126] References [ ",
            "cite_spans": [
                {
                    "start": 378,
                    "end": 382,
                    "text": "[97,",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 383,
                    "end": 386,
                    "text": "98]",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 630,
                    "end": 634,
                    "text": "[99]",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 635,
                    "end": 640,
                    "text": "[100]",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 641,
                    "end": 646,
                    "text": "[101]",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 647,
                    "end": 652,
                    "text": "[102]",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 653,
                    "end": 658,
                    "text": "[103]",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 659,
                    "end": 664,
                    "text": "[104]",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 665,
                    "end": 670,
                    "text": "[105]",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 671,
                    "end": 676,
                    "text": "[106]",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 1289,
                    "end": 1294,
                    "text": "[107,",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 1295,
                    "end": 1299,
                    "text": "108]",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 1409,
                    "end": 1414,
                    "text": "[109]",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 1585,
                    "end": 1590,
                    "text": "[110]",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 1591,
                    "end": 1596,
                    "text": "[111]",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 1597,
                    "end": 1602,
                    "text": "[112]",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 1603,
                    "end": 1608,
                    "text": "[113]",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 1609,
                    "end": 1614,
                    "text": "[114]",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 1615,
                    "end": 1620,
                    "text": "[115]",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 1621,
                    "end": 1626,
                    "text": "[116]",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 1627,
                    "end": 1632,
                    "text": "[117]",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 1633,
                    "end": 1638,
                    "text": "[118]",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 1737,
                    "end": 1742,
                    "text": "[119,",
                    "ref_id": "BIBREF100"
                },
                {
                    "start": 1743,
                    "end": 1747,
                    "text": "120]",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 1778,
                    "end": 1783,
                    "text": "[121]",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 2945,
                    "end": 2950,
                    "text": "[122]",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 3149,
                    "end": 3154,
                    "text": "[123]",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 3155,
                    "end": 3160,
                    "text": "[124]",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 3161,
                    "end": 3166,
                    "text": "[125]",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 3315,
                    "end": 3320,
                    "text": "[126]",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 3332,
                    "end": 3333,
                    "text": "[",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Subunit-based smallpox vaccines"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Clinical efficacy of intramuscular vaccinia immune globulin: a literature review",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Hopkins",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Lane",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Clin Infect Dis",
            "volume": "39",
            "issn": "6",
            "pages": "819--845",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bray",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Martinez",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "F"
                    ],
                    "last": "Smee",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Kefauver",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Thompson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Huggins",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Infect Dis",
            "volume": "181",
            "issn": "1",
            "pages": "10--19",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Buller",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Owens",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Schriewer",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Melman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Beadle",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "Y"
                    ],
                    "last": "Hostetler",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Virology",
            "volume": "318",
            "issn": "2",
            "pages": "474--81",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "F"
                    ],
                    "last": "Smee",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "W"
                    ],
                    "last": "Bailey",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Sidwell",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Antiviral Res",
            "volume": "52",
            "issn": "1",
            "pages": "55--62",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Smallpox: a potential agent of bioterrorism",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Whitley",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Antiviral Res",
            "volume": "57",
            "issn": "12",
            "pages": "7--12",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Production and use of biological weapons: need for international sanctions?",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Leitenberg",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Jama Aug",
            "volume": "6",
            "issn": "5",
            "pages": "387--395",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Biological weapons and secrecy (WC 2300)",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guillemin",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Faseb J",
            "volume": "",
            "issn": "13",
            "pages": "1763--1768",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "The looming threat of bioterrorism",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Henderson",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Science",
            "volume": "283",
            "issn": "5406",
            "pages": "1279--82",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Smallpox and its eradication. World Health Organization",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Fenner",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "A prospective study of serum antibody and protection against smallpox",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Mack",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Noble",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "B"
                    ],
                    "last": "Thomas",
                    "suffix": ""
                }
            ],
            "year": 1972,
            "venue": "Am J Trop Med Hyg",
            "volume": "21",
            "issn": "2",
            "pages": "214--222",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "The minimum protective level of antibodies in smallpox",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Sarkar",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Mitra",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "K"
                    ],
                    "last": "Mukherjee",
                    "suffix": ""
                }
            ],
            "year": 1975,
            "venue": "Bull World Health Organ",
            "volume": "52",
            "issn": "3",
            "pages": "307--318",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Deaths attributable to smallpox vaccination",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Lane",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "L"
                    ],
                    "last": "Ruben",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Abrutyn",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Millar",
                    "suffix": ""
                }
            ],
            "year": 1959,
            "venue": "",
            "volume": "212",
            "issn": "",
            "pages": "441--445",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Complications of smallpox vaccination, 1968: results of ten statewide surveys",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Lane",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "L"
                    ],
                    "last": "Ruben",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Neff",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Millar",
                    "suffix": ""
                }
            ],
            "year": 1970,
            "venue": "J Infect Dis",
            "volume": "122",
            "issn": "4",
            "pages": "303--312",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Halsell",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Riddle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Atwood",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gardner",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Shope",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Poland",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Jama",
            "volume": "289",
            "issn": "24",
            "pages": "3283--3292",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Smallpox vaccination: a review, part II",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "A"
                    ],
                    "last": "Fulginiti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Papier",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Lane",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Neff",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Henderson",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Clin Infect Dis",
            "volume": "37",
            "issn": "2",
            "pages": "251--71",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Smallpox vaccine and its stockpile in 2005. The Lancet infectious diseases Oct",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Arita",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "647--52",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Navigating the storm: report and recommendations from the Atlantic Storm exercise",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "T"
                    ],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "V"
                    ],
                    "last": "Inglesby",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Brimmer",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Borio",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Franco",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "K"
                    ],
                    "last": "Gronvall",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Biosecur Bioterror",
            "volume": "3",
            "issn": "3",
            "pages": "256--67",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Neff",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Modlin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Birkhead",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Poland",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Robertson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sepkowitz",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Clin Infect Dis",
            "volume": "46",
            "issn": "3",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine Mar 18",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Poland",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Grabenstein",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Neff",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "23",
            "issn": "",
            "pages": "2078--81",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Developing new smallpox vaccines. Emerging infectious diseases",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Rosenthal",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Merchlinsky",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Kleppinger",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Goldenthal",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "920--926",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Clinical responses to undiluted and diluted smallpox vaccine",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Frey",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Couch",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "O"
                    ],
                    "last": "Tacket",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Treanor",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wolff",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "K"
                    ],
                    "last": "Newman",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "N Engl J Med",
            "volume": "346",
            "issn": "17",
            "pages": "1265--74",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Talbot",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Stapleton",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Brady",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Winokur",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "I"
                    ],
                    "last": "Bernstein",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Germanson",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Jama Sep",
            "volume": "8",
            "issn": "10",
            "pages": "1205--1217",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Clinical and immune response to undiluted and diluted smallpox vaccine",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gassmann",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "B"
                    ],
                    "last": "Engler",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Steffen",
                    "suffix": ""
                },
                {
                    "first": "Alex",
                    "middle": [
                        "M"
                    ],
                    "last": "Czerny",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "P"
                    ],
                    "last": "Mutsch",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Swiss Med Wkly",
            "volume": "138",
            "issn": "",
            "pages": "392--399",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Couch",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Winokur",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Edwards",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Black",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Atmar",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Stapleton",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Infect Dis",
            "volume": "",
            "issn": "6",
            "pages": "826--858",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Hsieh",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "C"
                    ],
                    "last": "Sheu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "N"
                    ],
                    "last": "Hung",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Chou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Chang",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Vaccine",
            "volume": "24",
            "issn": "4",
            "pages": "510--515",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Policies in place throughout the world: action by the European Union",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Gouvras",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Int J Infect Dis",
            "volume": "8",
            "issn": "2",
            "pages": "21--30",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "P"
                    ],
                    "last": "Monath",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Caldwell",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Mundt",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Fusco",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Buller",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Int J Infect Dis",
            "volume": "8",
            "issn": "2",
            "pages": "31--44",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Osborne",
                    "suffix": ""
                },
                {
                    "first": "Da",
                    "middle": [],
                    "last": "Silva",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Frace",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Sammons",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Olsen-Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Upton",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Vaccine",
            "volume": "25",
            "issn": "52",
            "pages": "8807--8839",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax((R)) in healthy vaccinia-naive adults. Vaccine",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Frey",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "K"
                    ],
                    "last": "Newman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ennis",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Abate",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "F"
                    ],
                    "last": "Hoft",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "A novel, cell culturederived smallpox vaccine in vaccinia-naive adults",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "W"
                    ],
                    "last": "Artenstein",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "C"
                    ],
                    "last": "Marbury",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Morrison",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "S"
                    ],
                    "last": "Blum",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kemp",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Vaccine May",
            "volume": "9",
            "issn": "25",
            "pages": "3301--3310",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Marriott",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "V"
                    ],
                    "last": "Parkinson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "I"
                    ],
                    "last": "Morefield",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Davenport",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Nichols",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "P"
                    ],
                    "last": "Monath",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vaccine",
            "volume": "26",
            "issn": "4",
            "pages": "581--589",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "N"
                    ],
                    "last": "Greenberg",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Kennedy",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Expert Opin Investig Drugs",
            "volume": "17",
            "issn": "4",
            "pages": "555--64",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Vaccines for preventing smallpox. Cochrane database of systematic reviews (Online)",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Metzger",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "G"
                    ],
                    "last": "Mordmueller",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Smallpox vaccines: Past, present, and future",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Parrino",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "S"
                    ],
                    "last": "Graham",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Allergy Clin Immunol",
            "volume": "118",
            "issn": "6",
            "pages": "1320--1326",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Smallpox vaccines: from first to second to third generation",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Poland",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Lancet",
            "volume": "365",
            "issn": "9457",
            "pages": "362--365",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Smallpox vaccines for biodefense: need and feasibility",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "W"
                    ],
                    "last": "Artenstein",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Grabenstein",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Expert Rev Vaccines",
            "volume": "7",
            "issn": "8",
            "pages": "1225--1262",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Adventitious agents and smallpox vaccine in strategic national stockpile. Emerging infectious diseases",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Murphy",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "I"
                    ],
                    "last": "Osburn",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1086--1095",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Clonal vaccinia virus grown in cell culture as a new smallpox vaccine",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Weltzin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "V"
                    ],
                    "last": "Pugachev",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Myers",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Coughlin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "S"
                    ],
                    "last": "Blum",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nat Med",
            "volume": "9",
            "issn": "9",
            "pages": "1125--1155",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "N"
                    ],
                    "last": "Greenberg",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Clanton",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Plummer",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Hague",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cruz",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Lancet",
            "volume": "365",
            "issn": "9457",
            "pages": "398--409",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Wiser",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "D"
                    ],
                    "last": "Balicer",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Vaccine",
            "volume": "25",
            "issn": "6",
            "pages": "976--84",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sugimoto",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yamanouchi",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Vaccine",
            "volume": "12",
            "issn": "8",
            "pages": "675--81",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kidokoro",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tashiro",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shida",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Proc Natl Acad Sci",
            "volume": "102",
            "issn": "11",
            "pages": "4152--4159",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Empig",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Kenner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Perret-Gentil",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "E"
                    ],
                    "last": "Youree",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Bell",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Vaccine Apr",
            "volume": "24",
            "issn": "17",
            "pages": "3686--94",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mayr",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Stickl",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "K"
                    ],
                    "last": "Muller",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Danner",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Singer",
                    "suffix": ""
                }
            ],
            "year": 1978,
            "venue": "Zentralbl Bakteriol [B",
            "volume": "167",
            "issn": "56",
            "pages": "375--90",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Historical review of smallpox, the eradication of smallpox and the attenuated smallpox MVA vaccine",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mayr",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Berl Munch Tierarztl Wochenschr",
            "volume": "112",
            "issn": "9",
            "pages": "322--330",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Vollmar",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Arndtz",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Eckl",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Thomsen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Petzold",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mateo",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Vaccine Mar",
            "volume": "15",
            "issn": "12",
            "pages": "2065--70",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "N"
                    ],
                    "last": "Greenberg",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Expert Rev Vaccines",
            "volume": "8",
            "issn": "1",
            "pages": "13--24",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naive and vaccinia-immune individuals",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Parrino",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Mccurdy",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "D"
                    ],
                    "last": "Larkin",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "J"
                    ],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Rucker",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Enama",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Vaccine",
            "volume": "25",
            "issn": "8",
            "pages": "1513--1538",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "NYVAC: a highly attenuated strain of vaccinia virus",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tartaglia",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Perkus",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "K"
                    ],
                    "last": "Norton",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Audonnet",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "I"
                    ],
                    "last": "Cox",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Virology",
            "volume": "188",
            "issn": "1",
            "pages": "217--249",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tartaglia",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "I"
                    ],
                    "last": "Cox",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pincus",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Paoletti",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "NYVAC. Dev Biol Stand",
            "volume": "82",
            "issn": "",
            "pages": "125--134",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Midgley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Putz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "N"
                    ],
                    "last": "Weber",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Smith",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Gen Virol",
            "volume": "89",
            "issn": "",
            "pages": "2992--2999",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Safe and effective poxvirus vectors--NYVAC and ALVAC",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Paoletti",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tartaglia",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Dev Biol Stand",
            "volume": "82",
            "issn": "",
            "pages": "65--74",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Edghill-Smith",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Venzon",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Karpova",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mcnally",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nacsa",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "P"
                    ],
                    "last": "Tsai",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Infect Dis",
            "volume": "188",
            "issn": "8",
            "pages": "1181--91",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "W"
                    ],
                    "last": "Holzer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Remp",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Antoine",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pfleiderer",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "M"
                    ],
                    "last": "Enzersberger",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Emsenhuber",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Virol",
            "volume": "73",
            "issn": "6",
            "pages": "4536--4578",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "T"
                    ],
                    "last": "Ober",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bruhl",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schmidt",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Wieser",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Gritschenberger",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Coulibaly",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Virol",
            "volume": "76",
            "issn": "15",
            "pages": "7713--7736",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Coulibaly",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bruhl",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mayrhofer",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Schmid",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gerencer",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "G"
                    ],
                    "last": "Falkner",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Virology Oct",
            "volume": "10",
            "issn": "1",
            "pages": "91--101",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Supplement to the pathogenicity and immunogenicity of an attenuated vaccinia virus, strain DIs, in cynomolgus monkeys",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Tagaya",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Amano",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Komatsu",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Uchida",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kodama",
                    "suffix": ""
                }
            ],
            "year": 1974,
            "venue": "Japanese journal of medical science & biology",
            "volume": "27",
            "issn": "4",
            "pages": "215--243",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Improved plaque assay of a mutant of vaccinia virus, strain DIs, in chick embryo cell cultures",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Tagaya",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Amano",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yuasa",
                    "suffix": ""
                }
            ],
            "year": 1974,
            "venue": "Japanese journal of medical science & biology",
            "volume": "27",
            "issn": "4",
            "pages": "245--252",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ishii",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ueda",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Matsuo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Matsuura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kitamura",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kato",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Virology",
            "volume": "302",
            "issn": "2",
            "pages": "433--477",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Recombinant vaccinia DIs expressing simian immunodeficiency virus gag and pol in mammalian cells induces efficient cellular immunity as a safe immunodeficiency virus vaccine candidate",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Okamura",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Someya",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Matsuo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hasegawa",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Yamamoto",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Honda",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Microbiology and immunology",
            "volume": "50",
            "issn": "12",
            "pages": "989--1000",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ami",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Izumi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Matsuo",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Someya",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kanekiyo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Horibata",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Virol",
            "volume": "79",
            "issn": "20",
            "pages": "12871--12880",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Mechanisms of establishment of persistent SARS-CoV-infected cells",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Mizutani",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fukushi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ishii",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Sasaki",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kenri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Saijo",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Biochem Biophys Res Commun",
            "volume": "347",
            "issn": "1",
            "pages": "261--266",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Buller",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Cremer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Notkins",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Moss",
                    "suffix": ""
                }
            ],
            "year": 1985,
            "venue": "Nature",
            "volume": "317",
            "issn": "6040",
            "pages": "813--818",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Vijaysri",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Jentarra",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Heck",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Mercer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Mcinnes",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Jacobs",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vaccine",
            "volume": "",
            "issn": "5",
            "pages": "664--76",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Rodriguez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Rodriguez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Rodriguez",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Trauber",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Esteban",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "Proc Natl Acad Sci",
            "volume": "86",
            "issn": "4",
            "pages": "1287--91",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "H"
                    ],
                    "last": "Verardi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "H"
                    ],
                    "last": "Aziz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ahmad",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "D"
                    ],
                    "last": "Yilma",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Virol",
            "volume": "75",
            "issn": "1",
            "pages": "11--19",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Zhuang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Journal of virological methods",
            "volume": "144",
            "issn": "12",
            "pages": "17--26",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Legrand",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "H"
                    ],
                    "last": "Verardi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "D"
                    ],
                    "last": "Yilma",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "6",
            "pages": "2770--2779",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dai",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vaccine",
            "volume": "26",
            "issn": "",
            "pages": "5062--71",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "Reading",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Smith",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Virol",
            "volume": "77",
            "issn": "18",
            "pages": "9960--9968",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain. Vaccine",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Suter",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Meisinger-Henschel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tzatzaris",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Hulsemann",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lukassen",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "H"
                    ],
                    "last": "Wulff",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Loss of immunogenic properties of vaccinia virus inactivated by formaldehyde",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "R"
                    ],
                    "last": "Amies",
                    "suffix": ""
                }
            ],
            "year": 1961,
            "venue": "Can J Microbiol",
            "volume": "7",
            "issn": "",
            "pages": "141--52",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Inactivated smallpox vaccine. A comparison of inactivation methods",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Turner",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Squires",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "G"
                    ],
                    "last": "Murray",
                    "suffix": ""
                }
            ],
            "year": 1970,
            "venue": "J Hyg",
            "volume": "68",
            "issn": "2",
            "pages": "197--210",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "The immunogenicity of heat-inactivated vaccinia virus in rabbits",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "R"
                    ],
                    "last": "Madeley",
                    "suffix": ""
                }
            ],
            "year": 1968,
            "venue": "J Hyg",
            "volume": "66",
            "issn": "1",
            "pages": "89--107",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "The nature of the immune state produced by inactivated vaccinia virus in rabbits",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Boulter",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T"
                    ],
                    "last": "Zwartouw",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Titmuss",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "B"
                    ],
                    "last": "Maber",
                    "suffix": ""
                }
            ],
            "year": 1971,
            "venue": "American journal of epidemiology",
            "volume": "94",
            "issn": "6",
            "pages": "612--632",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "An antigenic difference between intracellular and extracellular rabbitpox virus",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Appleyard",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Hapel",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Boulter",
                    "suffix": ""
                }
            ],
            "year": 1971,
            "venue": "J Gen Virol",
            "volume": "13",
            "issn": "1",
            "pages": "9--17",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Poxvirus entry and membrane fusion",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Moss",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Virology",
            "volume": "344",
            "issn": "1",
            "pages": "48--54",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "The formation and function of extracellular enveloped vaccinia virus",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vanderplasschen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Law",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Gen Virol",
            "volume": "",
            "issn": "",
            "pages": "2915--2946",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Neutralizing and protective antibodies directed against vaccinia virus envelope antigens",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Galmiche",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Goenaga",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wittek",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Rindisbacher",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Virology",
            "volume": "254",
            "issn": "1",
            "pages": "71--80",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Davies",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Mccausland",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Valdez",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Huynh",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Hernandez",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Mu",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Virol",
            "volume": "79",
            "issn": "18",
            "pages": "11724--11757",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Hooper",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Custer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Schmaljohn",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Schmaljohn",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Virology",
            "volume": "266",
            "issn": "2",
            "pages": "329--368",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Wolffe",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Vijaya",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Moss",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Virology",
            "volume": "211",
            "issn": "1",
            "pages": "53--63",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Hooper",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Thompson",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wilhelmsen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zimmerman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Ichou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Steffen",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "9",
            "pages": "4433--4476",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "The role of particle-mediated DNA vaccines in biodefense preparedness",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Dean",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Haynes",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Schmaljohn",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Adv Drug Deliv Rev",
            "volume": "57",
            "issn": "9",
            "pages": "1315--1357",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Fogg",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lustig",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Whitbeck",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Eisenberg",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "H"
                    ],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Moss",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "",
            "pages": "10230--10237",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Aldaz-Carroll",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Ortiz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Whitbeck",
                    "suffix": ""
                },
                {
                    "first": "Alexander",
                    "middle": [
                        "E"
                    ],
                    "last": "Lou",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Vaccine",
            "volume": "25",
            "issn": "7",
            "pages": "1214--1238",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Hooper",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Custer",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Thompson",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Virology",
            "volume": "306",
            "issn": "1",
            "pages": "181--95",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Subunit recombinant vaccine protects against monkeypox",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Heraud",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Edghill-Smith",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ayala",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Kalisz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Parrino",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "S"
                    ],
                    "last": "Kalyanaraman",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Immunol",
            "volume": "177",
            "issn": "4",
            "pages": "2552--64",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Golden",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Hooper",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Virology",
            "volume": "377",
            "issn": "1",
            "pages": "19--29",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Aldaz-Carroll",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Whitbeck",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "De Leon",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Lou",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Virol",
            "volume": "81",
            "issn": "15",
            "pages": "8131--8140",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sakhatskyy",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "H"
                    ],
                    "last": "Chou",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kishko",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Virology Feb",
            "volume": "5",
            "issn": "1",
            "pages": "98--107",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "C"
                    ],
                    "last": "Tscharke",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Karupiah",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Palmore",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Irvine",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Haeryfar",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Exp Med",
            "volume": "",
            "issn": "1",
            "pages": "95--104",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mathew",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Terajima",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "West",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Green",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Rothman",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Ennis",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Immunol Feb",
            "volume": "15",
            "issn": "4",
            "pages": "2212--2221",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Jing",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Chong",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Byrd",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Mcclurkan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "T"
                    ],
                    "last": "Story",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Immunol",
            "volume": "178",
            "issn": "10",
            "pages": "6374--86",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Diversity in the acute CD8 T cell response to vaccinia virus in humans",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Jing",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Chong",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Mcclurkan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "T"
                    ],
                    "last": "Story",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Koelle",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Immunol",
            "volume": "175",
            "issn": "11",
            "pages": "7550--7559",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Snyder",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "M"
                    ],
                    "last": "Belyakov",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dzutsev",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Lemonnier",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Berzofsky",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "13",
            "pages": "7052--60",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "T-Cell epitope discovery for variola and vaccinia viruses",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Poland",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Rev Med Virol",
            "volume": "17",
            "issn": "2",
            "pages": "93--113",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "G"
                    ],
                    "last": "Ovsyannikova",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Madden",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Poland",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "C"
                    ],
                    "last": "Muddiman",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Am Soc Mass Spectrom",
            "volume": "16",
            "issn": "11",
            "pages": "1812--1819",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "Mass spectrometry and peptide-based vaccine development",
            "authors": [
                {
                    "first": "I",
                    "middle": [
                        "G"
                    ],
                    "last": "Ovsyannikova",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Bergen Hr 3rd",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Poland",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Clinical pharmacology and therapeutics",
            "volume": "82",
            "issn": "6",
            "pages": "644--52",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. Vaccine",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Moise",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Mcmurry",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Buus",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Frey",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "D"
                    ],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Groot",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "Recombinant subunit vaccines: potentials and constraints",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "G"
                    ],
                    "last": "Clark",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cassidy-Hanley",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Developments in biologicals",
            "volume": "121",
            "issn": "",
            "pages": "153--63",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "A novel, killed-virus nasal vaccinia virus vaccine",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "U"
                    ],
                    "last": "Bielinska",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Chepurnov",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Landers",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "W"
                    ],
                    "last": "Janczak",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "S"
                    ],
                    "last": "Chepurnova",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "D"
                    ],
                    "last": "Luker",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Clin Vaccine Immunol",
            "volume": "15",
            "issn": "2",
            "pages": "348--58",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Smallpox subunit vaccine produced in Planta confers protection in mice",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Golovkin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Spitsin",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Andrianov",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Smirnov",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pogrebnyak",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Proc Natl Acad Sci",
            "volume": "104",
            "issn": "16",
            "pages": "6864--6873",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "B"
                    ],
                    "last": "Jahrling",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Hensley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Martinez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Leduc",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "H"
                    ],
                    "last": "Rubins",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Relman",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "101",
            "issn": "42",
            "pages": "15196--200",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "Genetic predisposition for adverse events after vaccination",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Crowe",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Infect Dis",
            "volume": "196",
            "issn": "2",
            "pages": "176--183",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "The immunogenetics of smallpox vaccination",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Stanley",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Frey",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Taillon-Miller",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "D"
                    ],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "C"
                    ],
                    "last": "Koboldt",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Infect Dis",
            "volume": "196",
            "issn": "2",
            "pages": "212--221",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "Gender effects on humoral immune responses to smallpox vaccine",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "G"
                    ],
                    "last": "Ovsyannikova",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "S"
                    ],
                    "last": "Pankratz",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Vierkant",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Jacobson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Ryan",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Vaccine",
            "volume": "27",
            "issn": "",
            "pages": "3319--3342",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "Pharmacology, vaccinomics, and the second golden age of vaccinology",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Poland",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Clinical pharmacology and therapeutics",
            "volume": "82",
            "issn": "6",
            "pages": "623--629",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sakhatskyy",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "H"
                    ],
                    "last": "Chou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Virology",
            "volume": "355",
            "issn": "2",
            "pages": "164--74",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Pulford",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gates",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Bridge",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Robinson",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ulaeto",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Vaccine",
            "volume": "22",
            "issn": "",
            "pages": "3358--66",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "[11]. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med Sep;2003 9(9):1131-7. [PubMed: 12925846] [12]. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol Nov 15;2003 171(10):4969-73. [PubMed: 14607890] [13]. Combadiere B, Boissonnas A, Carcelain G, Lefranc E, Samri A, Bricaire F, et al. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med Jun 7;2004 199(11):1585-93. [PubMed: 15184506] [14]. Amanna IJ, Slifka MK, Crotty S. Immunity and immunological memory following smallpox vaccination. Immunol Rev Jun;2006 211:320-37. [PubMed: 16824139] [15]. Frey SE, Newman FK, Yan L, Lottenbach KR, Belshe RB. Response to smallpox vaccine in persons immunized in the distant past. Jama Jun 25;2003 289(24):3295-9. [PubMed: 12824212] [16]. Kim SH, Choi SJ, Park WB, Kim HB, Kim NJ, Oh MD, et al. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naive adults. Vaccine Aug 14;2007 25 (33):6287-91. [PubMed: 17597266] [17]. Taub DD, Ershler WB, Janowski M, Artz A, Key ML, McKelvey J, et al. Immunity from smallpox vaccine persists for decades: a longitudinal study. The American journal of medicine Dec;2008 121 (12):1058-64. [PubMed: 19028201] [18]. Ferrier-Rembert A, Drillien R, Tournier JN, Garin D, Crance JM. Short-and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine. Vaccine Mar 25;2008 26(14):1794-804. [PubMed: 18336966]",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "1]. Dixon, CW. Smallpox. J. & A. Churchill; London: 1962. [2]. Fenner, F.; Arita, I.; Jezek, Z.; Ladnyi, ID. Smallpox and its Eradication. W.H.O.; Geneva: 1988. DAH [3]. Jenner, E. An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox. Law; London: p. 1798 [4]. Cook GC. The smallpox saga and the origin(s) of vaccination. Journal of the Royal Society of Health Aug;1996 116(4):253-5. [PubMed: 8783857] [5]. Fenner F. A successful eradication campaign. Global eradication of smallpox. Rev Infect Dis Sep-Oct;1982 4(5):916-30. [PubMed: 6293036] [6]. Fenner F. The global eradication of smallpox. Med J Aust May 17;1980 1(10):455-5. [PubMed: 7412674] [7]. Wehrle PF, Posch J, Richter KH, Henderson DA. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull World Health Organ 1970;43(5):669-79. [PubMed: 5313258] [8]. Neff JM, Lane JM, Fulginiti VA. Smallpox and smallpox vaccination. N Engl J Med May 8;2003 348(19):1920-5. [PubMed: 12740965]author reply -5 [9]. Moore ZS, Seward JF, Lane JM. Smallpox. Lancet Feb 4;2006 367(9508):425-35. [PubMed: 16458769] [10]. Fenn, EA. Pox Americana: the great smallpox epidemic of 1775-82. Vol. 1st ed.. Hill and Wang; New York: 2001.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "Vaccine. Author manuscript; available in PMC 2010 November 5. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}